A First-in-Human Phase 1 Study of the Menin-KMT2A (MLL1) Inhibitor JNJ-75276617 in Adult Patients with Relapsed/Refractory Acute Leukemia Harboring KMT2A or NPM1 AlterationsElias Jabbour,Emma Searle,Maher Abdul-Hay,Sameem Abedin,Ibrahim Aldoss, Ana Alfonso Piérola,Juan Manuel Alonso-Dominguez,Patrice Chevallier, Carrye Cost,Nikki Daskalakis,Richard Dillon,Neil Dunavin,Jordi Esteve,Amir T. Fathi,Pasquale L. Fedele,Lucille Ferrante,Sylvain Garciaz,Christina Guttke,Emmanuel Gyan, Brett HiebertBlood(2023)引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要